Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GTS Internasional Tbk. (GTSI) vs Indofarma Tbk. (INAF) Price & Performance

GTS Internasional Tbk.Trade
Indofarma Tbk.Trade

Price performance (Past 24H)

Key statistics

GTS Internasional Tbk. vs Indofarma Tbk. — how do they compare? GTS Internasional Tbk. trades at Rp165 (market cap 2.64T, 20.64M 24h volume), while Indofarma Tbk. trades at Rp126 (market cap 390.51B). The key difference: GTS Internasional Tbk. is far larger — about 6.8× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.

GTSIINAF
Market Cap
2.64T390.51B
Volume
20.64M
Lot
206.42K
Turnover
3.34B
Average Price
161.78
Value
3.34B
Indicative Equilibrium Price
165
Indicative Equilibrium Volume
4.9K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GTSI
View details
INAF
View details

About GTS Internasional Tbk.

PT GTS Internasional Tbk (the “Company”) was established based on Notarial Deed No. 32 dated June 29, 2012 of Martina, S.H. The Company started its commercial operations in August 2019. The Company’s parent entity is PT Hateka Trans Internasional and ultimate parent entity is PT Humpuss Intermoda Transportasi Tbk.

Read more on GTSI

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF